# A Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics (PK) of a Single Intravenous (IV) TAK-954

> **NCT03296787** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 32 (actual)

## Conditions studied

- Renal Impairment
- Healthy Volunteers

## Interventions

- **DRUG:** TAK-954

## Key facts

- **NCT ID:** NCT03296787
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-21
- **Primary completion:** 2019-08-09
- **Final completion:** 2019-08-09
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2020-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03296787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03296787, "A Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics (PK) of a Single Intravenous (IV) TAK-954". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03296787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*